Published since 1884 by the Society for the Study of Addiction.
Editor-in-Chief, Robert West
Press Releases

Review Confirms Link between Drug Use and Poor Dental Health

Read More

Current controls on alcohol marketing are not protecting youth, warn public health experts

Read More

US and Mexican controls on precursor chemicals may reduce cocaine and methamphetamine use in the US

Read More

New study supports link between alcohol advertising and adolescent drinking

Read More

New review concludes that evidence for alcohol causing cancer is strong

Read More

UK government should fund media campaigns that promote quitting, not films that promote smoking

Read More

New study shows a generational shift toward lighter drinking in Australia

Read More

Prohibition 2016: Assessing the UK's Psychoactive Substances Act

Read More

The trouble with drinking guidelines: What, in the world, is a standard drink?

Read More

Take-home naloxone should be an additional standard of care for prevention of heroin overdose deaths

Read More

Nearly half of women who stop smoking during pregnancy go back to smoking soon after baby is born

Read More

E-cigarettes are estimated to have helped 16,000-22,000 smokers in England to quit in 2014

Read More

How to measure nicotine delivery from e-cigarettes

Read More

Smokers with depression try to quit more often but find it harder

Read More

Improvised Naloxone Nasal Sprays Lack Evidence of Absorption and Effect

Read More

New study finds financial incentives to help pregnant women stop smoking are highly cost-effective

Read More

The alcohol industry is not meeting its'Responsibility Deal' labelling pledges

Read More

The drug situation in Europe: Opioid misuse continues to dominate the picture

Read More

UK drinking guidelines are a poor fit with Britain's heavy drinking habits

Read More

Every country in the world can afford to support its smokers to stop

Read More

Progressively reducing the nicotine content of cigarettes may not lead smokers to quit

Read More

Children's exposure to second-hand smoke in England has dropped 80% since 1998

Read More

New study challenges claims on aldehyde contentof third generation e-cigarettes

Read More

A sobering thought: One billion smokers and 240 million people with alcohol use disorder worldwide

Read More

The more friends you drink with ... the more you drink

Read More

The growing evidence on standardised packaging of tobacco products

Read More

Plain packaging reduces 'cigarette-seeking' response by almost a tenth, says study

Read More

New study shows women have higher risk of injury than menafter more than three drinks

Read More

What twenty years of research on cannabis use has taught us

Read More

WHO-commissioned report on e-cigarettes misleading, say experts

Read More

New review says current evidence suggests potential benefits of e-cigarettes outweigh harm

Read More

Warning: Birthdays Can Be Bad for Your Health

Read More

Hazardous drinking in UK athletes linked with alcohol industry sponsorship

Read More

UK supermarkets minimise price rises for the cheapest alcohol when taxes are increased

Read More

E-cigarette use for quitting smoking is associated with improved success rates

Read More

Abstention from alcohol has increased sharply among Australian adolescents

Read More

Some truth to the 'potent pot myth': High potency cannabis is linked with higher THC intake

Read More

Alcohol consumption is a necessary cause of nearly 80,000 deaths per year in the Americas

Read More
Latest Press Releases
Editor's Note
Close
Open

We are delighted to announce our new team of Deputy Statistics & Methodology Editors: Emma Beard (University College London), Timothy Dobbins (University of New South Wales), Hayley Jones (University of Bristol), Jim Lewsey (University of Glasgow) and Sterling McPherson (Washington State University). They will join Statistics & Methodology Editor John Stapleton in providing statistical reviews as part of the peer review process.

Latest Key Findings
Current Issue

Existing economic evaluations of smoking cessation interventions lack information on one or more key study attributes necessary to be fully transferable to a new context.


Research since 2010 confirms the importance of alcohol use as a risk factor for disease and injuries; for some health outcomes, more than one dimension of use needs to be considered.


In Sweden exposure to increased alcohol availability during adolescence appears to be associated with an increased risk of receiving a disability pension in later life.


In Chile, men are at higher risk than women of being a passenger with an alcohol-impaired driver (PAID).


Cash incentives linked to a transdermal alcohol sensor can reduce heavy alcohol consumption while the incentives are in operation.


The use of buprenorphine for the treatment of opioid use disorder has increased markedly in the United States, but a substantial proportion of patients fill prescriptions for non-buprenorphine opioids during and following such treatment.


Heroin users in Australia show widely varying patterns of use over a 10-year period and it is proving difficult to predict which users will show which pattern.


Patients in Eastern Europe with opioid dependence are likely to experience additional barriers to accessing opioids over and above those experienced by non-dependent patients.


Participants in randomized controlled trials of pharmacological treatments for methamphetamine use disorder who are able to achieve a brief period of early abstinence are retained longer in the trials and are less likely to drop out overall.


Gambling disorder is associated with greater use of emotional suppression and middle frontal gyrus activation for regulating negative emotions, compared with healthy controls; both are linked with negative emotion-driven impulsivity in this disorder.


Participant drop-out in a 35-day trial of varying levels of reduced nicotine content cigarettes was greater for cigarettes with lower nicotine content and less in smokers reporting more favourable subjective ratings of the cigarettes.


Extended-release naltrexone (XR-NTX) is feasible and safe for treatment of opioid use disorder and alcohol use disorder in HIV clinics. Treatment initiation appears to be lower and retention greater for XR-NTX compared with treatment as usual.


There is evidence of an adverse association between substance use and sleep disturbance, which includes higher frequency of all substance use before substance misuse treatment and higher rates of cocaine use after a treatment episode.